Bifogade filer
2025-06 Completion of capital reduction.pdf
Kurs
-2,61%
Likviditet
77,1 MDKK
Kalender
| Est. tid* | ||
| 2025-08-12 | 07:50 | Kvartalsrapport 2025-Q2 |
| 2025-03-07 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2025-03-06 | - | Årsstämma |
| 2025-02-05 | - | Bokslutskommuniké 2024 |
| 2024-08-14 | - | Kvartalsrapport 2024-Q2 |
| 2024-03-07 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2024-03-06 | - | Årsstämma |
| 2024-02-06 | - | Bokslutskommuniké 2023 |
| 2023-08-15 | - | Kvartalsrapport 2023-Q2 |
| 2023-03-09 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2023-03-08 | - | Årsstämma |
| 2023-02-07 | - | Bokslutskommuniké 2022 |
| 2022-08-16 | - | Kvartalsrapport 2022-Q2 |
| 2022-03-11 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2022-03-10 | - | Årsstämma |
| 2022-02-08 | - | Bokslutskommuniké 2021 |
| 2021-08-12 | - | Kvartalsrapport 2021-Q2 |
| 2021-03-08 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2021-03-05 | - | Årsstämma |
| 2021-02-09 | - | Bokslutskommuniké 2020 |
| 2020-08-17 | - | Kvartalsrapport 2020-Q2 |
| 2020-03-11 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2020-03-10 | - | Årsstämma |
| 2020-02-04 | - | Bokslutskommuniké 2019 |
| 2019-08-14 | - | Kvartalsrapport 2019-Q2 |
| 2019-03-20 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2019-03-19 | - | Årsstämma |
| 2019-02-19 | - | Bokslutskommuniké 2018 |
| 2018-08-15 | - | Kvartalsrapport 2018-Q2 |
| 2018-03-23 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2018-03-22 | - | Årsstämma |
| 2018-02-22 | - | Bokslutskommuniké 2017 |
| 2017-08-14 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-09 | - | Kvartalsrapport 2017-Q1 |
| 2017-03-28 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2017-03-27 | - | Årsstämma |
| 2017-02-23 | - | Bokslutskommuniké 2016 |
| 2016-11-10 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-17 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-25 | - | Split DEMANT 1:5 |
| 2016-05-10 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-08 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2016-04-07 | - | Årsstämma |
| 2016-03-01 | - | Bokslutskommuniké 2015 |
| 2015-11-12 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-14 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-07 | - | Kvartalsrapport 2015-Q1 |
| 2015-04-10 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2015-04-09 | - | Årsstämma |
| 2015-02-26 | - | Bokslutskommuniké 2014 |
| 2014-11-13 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-14 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-08 | - | Kvartalsrapport 2014-Q1 |
| 2014-04-10 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2014-04-09 | - | Årsstämma |
| 2014-02-27 | - | Bokslutskommuniké 2013 |
| 2013-11-05 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-14 | - | Kvartalsrapport 2013-Q2 |
| 2013-05-07 | - | Kvartalsrapport 2013-Q1 |
| 2013-04-10 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2013-04-09 | - | Årsstämma |
| 2013-02-26 | - | Bokslutskommuniké 2012 |
| 2012-11-07 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-16 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-10 | - | Kvartalsrapport 2012-Q1 |
| 2012-04-12 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2012-04-11 | - | Årsstämma |
| 2012-02-29 | - | Bokslutskommuniké 2011 |
| 2011-11-10 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-19 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-12 | - | Kvartalsrapport 2011-Q1 |
| 2011-04-14 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
| 2011-04-13 | - | Årsstämma |
| 2010-11-16 | - | Kvartalsrapport 2010-Q3 |
| 2010-04-08 | - | X-dag ordinarie utdelning DEMANT 0.00 DKK |
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Large Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
4.4.2025 10:05:55 CEST | Demant A/S | Total number of voting rights and capital
Company announcement no 2025-06 | 4 April 2025 |
Completion of capital reduction in Demant A/S
As stated in company announcement no. 2025-04, it was decided at Demant A/S’ ordinary general meeting on 6 March 2025 to reduce the company’s share capital by nominally DKK 1,459,025.80 divided into 7,295,129 shares of DKK 0.20, corresponding to the company’s holding of treasury shares as at 4 February 2025 less shares to cover share-based retention programmes for senior leadership and the Executive Board.
The capital reduction was published via the electronic information system of the Danish Business Authority on 6 March 2025. The advertisement period expired without any objections being raised. Consequently, we have notified the Danish Business Authority of the capital reduction. After the capital reduction, the share capital of Demant A/S amounts to nominally DKK 42,758,932.60.
In accordance with section 32 of the Danish Capital Markets Act, we hereby state that the company’s total share capital and total number of voting rights amount to:
Share capital (nominal): DKK 42,758,932.60
Number of voting rights: 213.794.663
Further information: Søren Nielsen, President & CEO Phone +45 3917 7300 | Other contacts: René Schneider, CFO Peter Pudselykke, Head of Investor Relations Henrik Axel Lynge Buchter, Manager of External Communications |
Contacts
- Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.